Teledyne Technologies Incorporated (NYSE: TDY) — Wonderful Niche Businesses Earning Their Cost of Capital, Now Priced for the Defense Wave

Independent equity research note. Report date: 2026-07-04. Price reference: $652.08 (2026-07-02).

The analysis below (Sections 1–15) is position-free and contains no buy/sell recommendation and no price target — it discusses valuation only as embedded expectations and scenarios. The single, deliberately-fenced exception is the author’s opinion block immediately below.

⚡ Claude’s Take

This block is the author’s own subjective opinion and general information, not investment advice. Everything from the Executive Summary onward (Sections 1–15) is position-free and carries no price target.

Verdict: HOLD / great operator, wrong price — do not chase at $652; accumulate on weakness sub-~$560, genuinely attractive sub-~$510–520. Not a short. Conviction: medium.

Teledyne is a genuinely wonderful operating business wearing a merely-average capital-return suit, and at $652 you are paying the top-of-its-own-history multiple for the average part. The niche franchises are real — subsea connectors, LeCroy protocol analyzers, FLIR thermal detectors, e2v space sensors — and on a cash/tangible basis they earn ~45% returns, throw off ~$1.07B of high-quality, barely-SBC-diluted free cash flow, and sit on a de-levered, 25x-covered fortress balance sheet. That is why this is not a short: there is a real, organic, high-margin defense/drone/counter-drone/space inflection (book-to-bill 1.16 for ten straight quarters, $4.6B backlog), no impairment or solvency risk, and a cash engine that self-funds. But the thing you actually buy — TDY equity at book — has earned a ~7.4% reported ROIC that barely clears its ~8% cost of capital for four straight years, because 25 years and $12.8B of deals (FLIR chief among them) capitalized nearly all the excess return into $10.8B of goodwill (70.6% of assets; tangible book is negative). The organic algorithm is ~4%. So this is a bought-not-built compounder that must keep acquiring at cost-of-capital returns to grow — and it is now priced in the 92.7th percentile of its own decade P/S range, ~21x EV/EBITDA and ~32x GAAP earnings, after a ~35% momentum re-rating that flipped a low-beta defensive into a crowded defense-beta trade. AMETEK — the truest mirror — trades only ~1–2 turns richer for ~7 points more margin and higher returns; TDY is the cheaper, lower-quality way to own the theme, not a bargain.

The framing is “quality-compounder-at-the-wrong-price meets a momentum re-rating.” The 2026 move is a multiple event, not an earnings breakout — non-GAAP EPS is compounding ~8–17% while the multiple expanded ~25%. Bullish flip: two-plus years of durable ~6%+ organic growth and group ROIC climbing toward low-double-digits (i.e., the defense supercycle proves structural and M&A finally lifts returns). Bearish flip: book-to-bill slips below 1.0 for two-plus quarters or an out-of-pattern, richly-priced acquisition lands under the new CEO — with founder-allocator Robert Mehrabian stepping back to Executive Chairman (yet still the highest-paid officer at $9.8M), the succession is the wildcard on the one skill this whole model depends on. Tag: “Singleton’s heirs at full price — a portfolio of great niches earning its cost of capital, re-rated on a war.”

📈 Stock Price Action — Five-Year Event Map

Arc. From a COVID trough near $234 (Mar 2020), TDY compounded steadily to ~$465 (end-2024) and ~$511 (end-2025), then broke out violently in early 2026 to an all-time high of $688.59 (Mar 2 2026) on the defense/drone/space inflection — a ~35% move in nine weeks — before settling to $652.08 (Jul 2 2026). The 52-week range is $484.50–$688.60; the stock sits ~5% below its all-time high and near the top of its own decade valuation range.

Cycle narrative. (1–2) The FLIR era: the 2021 acquisition drove the revenue step-change, but the stock had already priced it (~46x P/E, ~5.2x EV/Sales), leaving little room. (3) 2022’s rate shock compressed the multiple ~20% as the market repriced richly-valued industrial-tech. (4–5) A multi-year grind back to highs on steady defense and, in 2025, a broad recovery led by FLIR-Defense/unmanned and IR components. (6) The breakout catalyst was the Q4-25 earnings release on Jan 21 2026 — a record quarter that popped the stock ~10% in a day. (7) Momentum carried it to the $688.60 ATH by Mar 2 on drone/counter-drone/space-sensor headlines as the name re-tagged from defensive-industrial to defense-beta. (8) It gave back ~15% into end-March, then the Q1-26 beat-and-raise (Apr 22) re-anchored it in the ~$610–660 range, closing $652 on Jul 2. (Price moves are FACT; attributed drivers are INTERPRETATION. No price target, no support/resistance.)

1. Executive Summary

Teledyne Technologies is a $6.1bn-revenue federation of niche instrumentation, digital-imaging and defense-electronics businesses, assembled almost entirely by acquisition — roughly 75 deals over 25 years for ~$12.8bn, the ~$8bn FLIR purchase (2021) chief among them. It sells high-reliability, high-mix, low-volume hardware into a dozen specialized end-markets: machine vision and thermal/IR imaging, space and scientific sensors, marine and environmental instrumentation, electronic test & measurement, and defense electronics/unmanned systems. Four segments: Digital Imaging (52% of sales), Instrumentation (24%), Aerospace & Defense Electronics (17%), Engineered Systems (7%).

The operating businesses are excellent and the capital-return profile is only average — and that tension is the entire investment case. On a cash/tangible basis the franchises earn ~45% returns, generate ~$1.07bn of free cash flow (1.2x net-income conversion, <1% SBC dilution), carry 42.8% gross and 24.3% EBITDA margins, and sit behind a de-levered balance sheet (~1.5x net leverage, ~25x interest coverage). But reported ROIC has been ~7.4% for four years — barely its ~8% cost of capital — because $10.8bn of goodwill and intangibles (70.6% of assets; negative tangible book equity) capitalizes almost all of the excess return into the prices paid to sellers. Organic growth is low-single-digit (~4%); FY2024 total revenue rose only +0.6% and FY2025’s +7.9% was overwhelmingly acquired (Qioptiq).

What changed in 2026 is a genuine, organic, high-margin defense inflection — drones (Black Hornet nano-UAV, Rogue 1 loitering munition), counter-UAS, electronic warfare, maritime autonomy, and space sensing (SDA tranches, “Golden Dome”) — with book-to-bill above 1.0 for ten consecutive quarters and a $4.6bn backlog. Management raised FY2026 guidance to ~$6.415bn revenue (~4.9% growth, ~4% organic), GAAP EPS $20.08–$20.44, non-GAAP EPS $23.85–$24.15.

The market has responded: the stock re-rated ~35% into a March-2026 all-time high of $688.59 and trades at $652 — ~21x EV/EBITDA, ~27x forward non-GAAP / ~32x GAAP earnings, ~5.0x sales, a ~3.6% free-cash-flow yield, and the 92.7th percentile of its own decade P/S range. Embedded expectations imply ~4.5% perpetual FCF growth at an 8% discount rate — achievable, but only if Teledyne keeps deploying capital at returns that barely beat its cost of capital, and only if the defense wave proves durable. This is a very good company and an ordinary compounder of capital, now priced for the good case, with a founder-to-successor CEO transition adding a governance/key-person asterisk over the one skill — capital allocation — the model depends on.

2. Business Overview

What Teledyne is. A diversified technology company that, in its own words, “provides enabling technologies to sense, analyze and distribute information for industrial growth markets that require advanced technology and high reliability” (FY2025 10-K, Item 1). The through-line is high-reliability, high-mix, low-volume hardware for demanding physical/technical environments — not a single product, platform, or recurring-revenue engine. Scale was bought, not built: 75 acquisitions in 25 years for ~$12.8bn, with FLIR (~$8bn, 2021) roughly doubling the company.

Segment structure (FY2025, from segment MD&A / Note 4):

What each segment does:

• Digital Imaging (52%, FLIR-created). Sensors, cameras and systems across visible / infrared / UV / X-ray, plus MEMS and high-reliability semiconductors. A split personality: commercial machine-vision imagers (Teledyne DALSA / e2v), thermal cores & cameras (Teledyne FLIR), and X-ray on one side; defense EO/IR, lasers/optics/radar, CBRNE detection and unmanned air/ground/sea systems on the other. FY25 grew only +3.0% (commercial IR components +$55.9M, unmanned air +$35.1M, surveillance +$28.7M; offset by IR systems −$25.2M and X-ray −$14.2M). Reported margin 16.7% is depressed by $185.3M of acquired-intangible amortization (5.9% of segment sales) — ex-amortization it runs ~22.6%.
• Instrumentation (24%, the margin king at 27.5%). Marine (subsea connectors/penetrators, sonar, autonomous underwater vehicles — offshore energy, naval, oceanographic); Environmental (air/water/emissions monitoring, lab and gas/flame detection); Test & Measurement (Teledyne LeCroy oscilloscopes and protocol analyzers). FY25 +5.4%, led by marine +$48.6M. The 27.5% margin sits on only ~$13M of amortization (0.9% of sales) — margin earned from product and IP, not accounting.
• Aerospace & Defense Electronics (17%, +36% on Qioptiq). Components and subsystems: harsh-environment interconnects, avionics and data-acquisition systems, general-aviation batteries, satcom. $244.2M of the $281.9M FY25 increase was acquired (Excelitas/Qioptiq). Margin fell to 24.8% (from 28.5%) on inventory step-up and integration costs — a live example of bolt-ons diluting near-term returns before the optimization playbook runs.
• Engineered Systems (7%, weak at 10.7%). Government-project systems integration, specialty electronics, energy/marine systems for NASA, the Department of War (DoW) and DoE. 84.5% U.S.-Government, 1.3% international; revenue −0.9% and guided to soften on NASA budget pressure. Commodity project work with no pricing power.

How it makes money. Revenue is roughly ~60% point-in-time (short-cycle commercial product sales) and ~40% over-time (cost-to-cost engineered/defense work; Qioptiq lifted the over-time share) — a blend of short-cycle industrial product sales and longer-cycle defense/engineered projects, with no meaningful recurring or aftermarket annuity. Investors should not credit software-like economics here: this is hardware and project revenue. Remaining performance obligations (backlog) stand at $4,611.7M (0.75x sales), 71% recognizable within 12 months — solid coverage but not a subscription book.

Customer and geographic mix. No commercial customer exceeds 10% of sales; U.S. Government is 25.5% ($1,559.4M; DoW $1,203.6M / ~19.7%), and 81% of U.S.-Government contracts are fixed-price (cost risk on Teledyne). International is ~48% ($2,932.6M across 100+ countries; top-five UK/Germany/Japan/China/France ~20%). Total defense exposure is ~30–35% and rising. Workforce ~15,800 across 38 countries, ~10-year average tenure, ~8% turnover.

The Teledyne model. A decentralized federation run for margin and cash by a long-tenured team: buy niche #1/#2 businesses, integrate onto shared overhead, contain costs, expand margins, and redeploy the cash (FY25 operating cash flow $1,191.3M) across capex, M&A, buybacks and debt reduction. R&D is a moderate ~$317.3M (~5.2% of sales) — this is a buy-and-optimize, not invent-and-scale, business.

Verdict — a well-run, cash-generative, but structurally ordinary hardware federation. Two excellent segments (Instrumentation, A&D), one large-but-mixed (Digital Imaging), one weak (Engineered Systems). Respectable aggregate economics and a genuine cash engine — but product/project hardware, not a recurring annuity, and scale that was bought rather than built. The model works; it is not obviously special.

3. Industry Dynamics

Teledyne plays in roughly a dozen niche end-markets. Two questions matter: is the portfolio of industries attractive, and is the roll-up game that assembles it still favorable? The answers are mixed-to-good on the first and clearly late-cycle on the second.

• Machine vision (~$15–18bn, ~8% CAGR). Led by Cognex (~21%) and Keyence (~19%), then Basler/Omron/Teledyne. Teledyne plays as a component/sensor supplier (CMOS/CCD, line-scan sensors, frame grabbers) — structurally weaker than Cognex/Keyence, who own the software and installed base. Asia-Pacific is both the growth pool and the competitive threat.
• IR / thermal & defense EO/IR (the best niche). A genuine oligopoly: FLIR, Lynred, Leonardo DRS and Northrop hold >80% of high-performance detector capacity. Detector fabrication is capital- and know-how-intensive (real barriers) with platform lock-in (real switching costs). Defense EO/IR is a ~$15bn market by 2035. Genuinely defensible.
• Scientific / space sensors (e2v). Small, near-sole-source, with extreme barriers (radiation-hardening, qualification, flight heritage). Excellent economics, limited size.
• Marine / subsea (Instrumentation). Fragmented and high-barrier, cyclical to offshore energy and naval spending. Connectors and penetrators are designed-in and qualification-gated (real switching costs); a strong niche versus Kongsberg.
• Environmental. Regulation-driven, defensive and steady — a quality ballast to the cyclical lines.
• Test & measurement (LeCroy). Oligopoly: Keysight #1, Rohde & Schwarz, Tektronix (Fortive/Ralliant), then LeCroy #3, strongest in protocol analysis. Good structure, smaller player, cyclical to semiconductor and data-center design activity.
• Defense electronics / avionics (A&D). Fragmented subsystem supply — designed-in, ITAR-gated, sticky but budget-dependent; boosted by Qioptiq and European rearmament (though EU local-content rules are a growing barrier to a U.S. supplier).
• Space / engineered systems. NASA/DoW budget-hostage — the least attractive, most commoditized, lowest-margin line.

The defense / drone / counter-drone / space cycle. These are genuine multi-year tailwinds — counter-UAS, EO/IR/ISR, unmanned systems, and space sensing pulled by the Space Development Agency’s tranche architecture and the “Golden Dome” concept. But Teledyne is a components/subsystems supplier, not a prime, so it captures a slice of the wave and remains exposed to appropriations timing, continuing resolutions and shutdown risk.

Regulation. ITAR/EAR is double-edged — a barrier to foreign entrants but a constraint on Teledyne (China has added Teledyne entities to its Unreliable-Entity / export-control lists; China/India/Saudi/EU local-content rules erode the addressable market). The 81% fixed-price U.S.-Gov mix shifts cost risk onto Teledyne. Legacy FLIR trade-compliance and tax matters remain open items.

Capital-cycle (Marathon lens). The “buy niche instruments and optimize” strategy is no longer proprietary. AMETEK, Roper, Danaher, Halma, Judges Scientific, Fortive/Ralliant and financial sponsors all hunt the same bolt-ons; management concedes rivals have “greater resources than we do” and, tellingly, complains that buyers “are willing to pay some outrageous prices to get the revenue.” High historical returns have attracted capital: quality-instrument multiples now sit in the high-teens/low-20s EV/EBITDA, which is precisely why Teledyne’s incremental ROIC is single-digit. The operating industries remain attractive; the market for buying them is expensive.

Verdict — a structurally good collection of niches entered through an increasingly expensive door. Most of Teledyne’s end-markets are high-barrier, specialized, non-commoditized, and several are oligopolistic (thermal/IR, oscilloscopes, subsea), with real defense/space/counter-UAS tailwinds and defensive environmental demand. But the portfolio is fragmented, cyclically exposed (offshore energy, semis, commercial aero, government budgets), threatened at the edges by subsidized Asian competition and local-content rules, and the roll-up game is crowded and richly priced. Good industries; a poor point in the capital cycle to be the marginal buyer.

4. Competitive Position

The central question: is there a company-level moat, or is this a competent conglomerate of decent niches? The evidence points firmly to the latter — the advantages live inside the operating units, and the price paid to assemble them left the enterprise earning roughly its cost of capital.

Moat by segment (Greenwald taxonomy):

• Instrumentation — switching costs + intangibles (genuine). A 27.5% margin on 0.9%-of-sales amortization is product-driven, not accounting-driven. Subsea connectors/penetrators, sonar and LeCroy protocol analyzers are designed-in, qualification-gated and mission-critical. The moat is proven by the financial outcome.
• A&D Electronics — switching costs (program-locked, ITAR-gated). A 24.8% margin from components designed onto multi-year platforms, sole/dual-sourced with long qualification cycles. Sticky, but budget-dependent.
• Digital Imaging — mixed. A real moat in IR (FLIR) and space sensors (e2v) — intangibles plus detector-fab scale and oligopoly. Weak in machine vision (DALSA) — a component supplier against Cognex/Keyence, who own the software and installed base. The blended 16.7% (22.6% ex-amortization) sits below Instrumentation/A&D, revealing diluted pricing power.
• Engineered Systems — no moat. 10.7% margin, 84.5% U.S.-Gov, NASA-hostage, commodity project work.

A corporate moat? No. Management states plainly that “each of our markets is highly competitive … many of our competitors have … greater … resources than we do.” There is no shared customer, no cross-segment network effect, no company-wide scale advantage. The only enterprise-level edge is a capital-allocation and cost-containment culture — a management attribute, copyable by AMETEK/Roper, that does not survive a Greenwald test.

The killer statistic — ROIC vs WACC. Company ROIC is ~7.4% (ROE 13.3%) against an estimated ~8–9% WACC: the enterprise, as assembled at the prices paid, earns roughly — or below — its cost of capital. Goodwill of $8,687.6M plus net intangibles of $2,100.1M equals $10.79bn, or 70.6% of total assets — most of the economic rent was capitalized into purchase prices and transferred to sellers. The FLIR fingerprint is unmistakable: ROIC ran 10.9% pre-FLIR (FY2020), fell to 6.6% at close (FY2021), and has been stuck at 6.6–7.8% every year since. A single ~$8bn deal, ~⅔ goodwill/intangibles, roughly halved company ROIC and it has not recovered.

Peer comparison (ROIC.ai, FY2025):

Three conclusions follow. (1) TDY’s 7.4% is not uniquely bad — Roper (6.3%) and Danaher (5.7%) report lower; the whole premium-serial-acquirer cohort earns mid-single-digit ROIC by capitalizing premia. (2) But TDY carries the DHR/ROP-style goodwill drag without their recurring-software or consumables economics — 42.8%-gross-margin hardware is lower-quality collateral for the same balance-sheet load. (3) AMETEK is the standing rebuke: 12.6% ROIC and 25.8% operating margin on lower gross margin, achieved by running leaner and paying disciplined multiples for smaller bolt-ons rather than one $8bn platform.

Verdict — durable niche advantages, no durable company-level moat, returns roughly at cost of capital. Real switching-cost and intangible advantages exist inside Instrumentation, A&D, and the IR/space parts of Digital Imaging (proven by 25–28% segment margins and stable niche share). But there is no scale/network/switching-cost edge at the corporate level; the only company-wide advantage is an operating-discipline culture — a management attribute, not a structural moat. 7.4% ROIC vs ~8–9% WACC is the honest summary: good businesses bought at prices that transferred most of the rent to sellers. AMETEK proves it can be done better; Roper/Danaher prove TDY is not the worst offender. Teledyne sits in the middle — a very good company and an ordinary compounder of capital.

5. Growth History and Forward Opportunities

Historical growth — a 2021 acquisition step-change, then modest organic. Teledyne’s five-year revenue record is a textbook serial-acquirer signature: one large step-change from a transformational deal, then low-single-digit organic in the intervening years, punctuated by bolt-ons.

The fact the top line hides: two of the five growth years (2021–22) came almost entirely from acquiring FLIR; the three organic years that followed (2023–25) averaged only ~3.9% total revenue growth, and FY2024 was essentially flat. The FLIR-specific interpretation is unflattering: Teledyne paid a full price (~$8bn, mid-teens EV/EBITDA) for a business that had been a serial disappointer under prior management, and IR imaging/surveillance only re-accelerated to >20% growth in 2025 on the European/Ukraine defense wave — the payoff arrived from an exogenous demand shock, not from a Teledyne-specific value-creation lever. The underlying organic algorithm of the whole company is mid-single-digit.

FY2025 composition and Q1-26 momentum. Digital Imaging (52%) +3.0% but with IR components/subsystems +>20% and unmanned air double-digit; Instrumentation +5.4% (marine +8%, subsea AUVs +>20%, environmental +6.7%, but test & measurement −3.7% on the oscilloscope/protocol cycle); A&D +36.3% (largely acquired); Engineered Systems −2.6%/lumpy. The Q1-2026 headline was strong — sales +7.6%, organic +6.9%, non-GAAP EPS +17.2%, book-to-bill 1.16 (tenth consecutive quarter >1), backlog ~$4.6bn.

Forward opportunities.

1. Defense / unmanned / counter-drone — the 2026 story. Defense is ~30–35% of revenue (~$2bn); the unmanned line (~$500M and growing fastest) spans the Black Hornet PRS nano-UAV, Rogue 1 loitering munition at full-rate production, counter-UAS, EW and maritime surveillance, plus SDA/“Golden Dome” space-sensor wins. This is the genuinely new, demand-led, high-margin leg.
2. Industrial short-cycle recovery. Machine vision, X-ray, MEMS (+~20%) and test & measurement inflecting off a 2023–24 trough — real but cyclical mean-reversion, not secular acceleration.
3. Test & measurement content cycle. PCIe Gen6 and 800G/1.6T optical-networking test refresh should lift the LeCroy lines through 2026–27.
4. M&A optionality. A de-levered balance sheet (~1.5x) plus >$1bn/yr FCF gives dry powder, and management is explicitly hunting. This is the market’s implicit growth assumption — see the Valuation discussion.

Verdict — mixed-quality growth, defense-led but structurally M&A-dependent. The durable, high-return organic algorithm is only ~4–5%, and much of the multi-year top line has been bought, not grown. The 2025–26 defense/unmanned/space inflection is real, organic and high-margin — genuinely positive — but it is partly exogenous (rearmament, Golden Dome) and not yet proven durable across a full cycle. High-quality segments, average-quality aggregate: low-to-medium-quality growth.

6. Financial Quality

Revenue quality. As Section 5 shows, Teledyne is a low-single-digit organic grower wearing an acquisition-fed top line; the FY2025 +7.9% is overwhelmingly Qioptiq. That composition is the reason reported returns sit near the cost of capital.

Margin trajectory — real lift since FLIR, now flattened. Gross margin expanded ~290bps (39.9%→42.8%) and operating margin ~530bps (13.5%→18.8%) from FY2021 to FY2025; EBITDA margin 21.6%→24.3%. Some of the FY2021 depression was the partial-year FLIR drag and purchase-accounting step-ups, but the multi-year climb is genuine integration synergy plus mix. Crucially, margins are essentially unchanged FY2023→FY2025 (43.3%/18.4% → 42.8%/18.8%) — the easy post-FLIR harvest is largely done; further margin gains must come from mix (defense, T&M recovery) and fresh deal-optimization.

Cash generation — the genuine strength.

FY2022’s 0.50x conversion was a working-capital air-pocket (inventory −$155M, payables −$298M), not structural. FY2024–25 FCF of ~$1.1bn/$1.07bn converts at 1.2–1.35x of net income — structurally helped by the ~$217M of non-cash amortization that depresses reported net income but not cash. FY2026 guidance is >$1.0bn FCF (management aspires to ~$1.1bn) with CapEx rising to ~$150M from an $84–117M base (still <2% of sales). This is a low-capital-intensity compounder at the cash level.

Share count and SBC — clean and non-dilutive. SBC is trivial for a $6bn tech-industrial — $39.6M in FY2025, ~0.65% of revenue — versus $1.07bn of FCF; there is no SBC-flattered-FCF problem here (contrast software peers). Diluted share count has drifted down: 47.7M (FY22) → 47.4M (FY25) → 46.8M in Q1-2026, as buybacks now exceed dilution. A clean equity story.

ROIC and the goodwill problem — the skeptical crux. Reported returns are mediocre for a “quality compounder”: ROIC ~7.4% (NOPAT ≈ EBIT $1,149.8M × (1−18.2%) ≈ $940M over ~$12.8bn invested capital), barely covering an estimated ~8% WACC; ROE 13.3%; ROA 6.1%. The reason the numbers look pedestrian while the underlying businesses are excellent is goodwill and acquired intangibles from 25 years of dealmaking: $10,787.7M, or 70.6% of total assets, exceeding the entire $10,513.9M of book equity — so tangible book equity is negative (≈ −$274M; −$5.93/share) and P/TBV is meaningless. Back out the intangibles and tangible ROIC is ~45%+: the operating businesses are genuinely high-return; the gap between ~45% tangible and ~7.4% reported ROIC is the acquisition premium Teledyne has paid. The negative tangible book is not a distress signal (it is normal for a serial acquirer) — it is a valuation signal: you are buying a portfolio marked at acquisition cost, and the marginal deal must clear a high bar to add value.

Quality of earnings — three flags.

1. GAAP-to-non-GAAP bridge is mostly amortization. GAAP diluted EPS was $18.88 (FY25) / $17.21 (FY24) / $18.49 (FY23). The ~$3–4 gap to management’s non-GAAP figure is almost entirely acquired-intangible amortization: $216.6M in FY2025 (≈$3.5–3.7/diluted share after tax). The add-back is non-cash and real — but it is also recurring and only slowly declining (scheduled $219.1M in 2026 down to $138.8M by 2030) and is refreshed upward by every new deal. Treat non-GAAP EPS as a legitimate cash proxy, not as evidence the charge is a one-time item.
2. Effective tax-rate volatility. The rate swung from 7.5% (FY23) → 12.5% (FY24) → 18.2% (FY25), driven by reversals of unrecognized tax benefits (large in FY23, smaller in FY25) plus a ~$30M FY25 cash-tax cut from the July-2025 tax act. FY2023’s ~$18.49 EPS was flattered by ~$1.90 of tax artifact; FY2025’s 18.2% is the cleaner baseline. Q1-2026 again carried an $8.0M discrete benefit (~$0.17/share). Normalize the tax line before drawing EPS-trend conclusions.
3. Working capital. Inventory rose to $1,043.3M (+14%, faster than +7.9% sales; partly acquired); the cash-conversion cycle stretched to ~113 days from ~79 in 2021. A mild watch-item, not alarming; accounting is otherwise conservative (no capitalized-software games).

Balance sheet — de-levered fortress. Net debt fell from $3.6bn (FY21) to ~$2.29bn (FY25): net leverage ~1.5x (a five-year low), EBITDA/interest ~25x. Debt is $2,489.0M of fixed-rate senior notes on a laddered schedule ($450M 2026, $700M 2028, $427M 2030, $911M thereafter), plus a fully-undrawn $1.20bn revolver. In FY25 Teledyne opportunistically retired $177.0M of its own notes at a discount for a $15.0M gain — a small, shareholder-friendly signal. Ample dry powder for the next deal.

Verdict — economics improve with scale at the operating level, only marginally at the shareholder level. A high-return operating engine (tangible ROIC ~45%, FCF ~$1.07bn at 1.2x conversion, non-dilutive, margin-rich, fortress balance sheet) is bolted to a merely-average capital-return profile: reported ROIC ~7.4%, barely WACC, because nearly all the excess return has been capitalized into $10.8bn of goodwill (70.6% of assets; negative tangible book). Scale has grown absolute FCF; per-dollar-of-invested-capital economics have not improved.

7. Capital Allocation

The M&A engine is the capital-allocation story. Teledyne is, functionally, a diversified serial acquirer in the Danaher/Roper mold — ~75 acquisitions over ~25 years for ~$12.8bn (~$10.8bn cash, ~$4bn stock). The playbook: buy niche #1/#2 sensor/instrumentation/imaging businesses, integrate onto shared overhead, apply operational-effectiveness programs, expand margins, redeploy the cash. FY2025 alone deployed $821.4M — led by Excelitas/Qioptiq (~$702.8M, aerospace/defense optics), plus bolt-ons Micropac (Dec-24), Adimec (Mar-25), TransponderTech from Saab (Nov-25) and DD-Scientific (Jan-26).

Discipline check — real on leverage, average on aggregate returns. The stated philosophy (Mehrabian’s oft-repeated line that Teledyne “will not pay outrageous prices”) is partially corroborated: FY2022–2024 acquisition spend was deliberately throttled to $78–124M/yr while the company paid down FLIR debt rather than chase deals into a high-multiple market — genuine counter-cyclical restraint. The Qioptiq deal re-opened the wallet only once the balance sheet was repaired. But the ~7.4% group ROIC is itself the scoreboard: disciplined on the price of any single deal, the aggregate multiple paid over 25 years still leaves little excess return for the equity buyer.

FLIR retrospective — the defining decision. The ~$8.0bn FLIR acquisition (closed May 2021, ~$4bn debt-funded) is the deal to judge management on, and the evidence is mixed-to-favorable. Favorable: FLIR is why Digital Imaging is a $3.2bn segment and why group EBITDA margin climbed ~270bps; the debt was fully retired within ~3 years; no impairment of the FLIR core has been taken. Skeptical: ~$8bn was paid at roughly mid-teens EV/EBITDA for a business whose organic growth has since been low-single-digit, and the deal did not lift group ROIC above WACC. A competent, well-integrated, well-financed acquisition of a good asset at a fair-to-full price — value-neutral-to-modestly-accretive, not a home run.

Buybacks now the swing use of cash; no dividend. With leverage repaired, capital return has stepped up: buybacks of $402.9M (FY25) and $354.0M (FY24) — enough to shrink the diluted count. In July 2025 the Board authorized a new $2.0bn repurchase program (no expiration; ~$1.96bn remained at year-end after buying ~577k shares at ~$505–524 in Q4). Repurchasing near record levels is programmatic return of excess FCF — acceptable, but not opportunistic value-buying. No dividend, and none contemplated (10-K, verbatim) — reasonable for a compounder, but it means the entire shareholder return depends on capital-allocation skill (deals + buybacks) rather than a cash yield.

R&D / opex intensity. Company-funded R&D of ~$317.3M (~5.2% of sales) is down from $356.3M (FY23) — moderate for the sector; Teledyne buys technology more than it invents it. SG&A ~$931M (15.2% of sales). Well-controlled.

Incentive alignment — sound, but no capital-return gate. The 2026 proxy metrics are operationally reasonable but omit an explicit ROIC/return-on-capital gate — a notable gap given the group-ROIC-near-WACC problem. The Annual Incentive Plan weights 40% adjusted pre-tax income, 25% adjusted revenue, 15% managed working capital, 20% individual — it pays for working-capital discipline but not for margin or capital efficiency, and “adjusted” earnings/revenue can be grown by acquisition. The long-term plan ties to three-year revenue, EPS, managed working capital and relative TSR, and it paid below target for the 2023–2025 cycle when performance lagged — a genuine positive. Say-on-Pay approval was 95.6%.

Governance flag — the Executive Chairman. Robert Mehrabian, who ran Teledyne as CEO for two decades, remains Executive Chairman and was the highest-paid executive at $9,787,488 in FY2025 — more than double new CEO George Bobb III’s $4,255,049. Bobb was promoted to President & CEO on April 28, 2025, succeeding Edwin Roks (who departed with $1.8M severance). Paying a non-CEO Executive Chairman the single-largest package signals Mehrabian still holds the reins — a real succession/key-person overhang on the one skill this model depends on. Insider alignment is otherwise modest: all directors and officers own just 1.3% of the class (Mehrabian 200,722 shares / ~0.43%; Bobb 26,572), and the Form 4 corpus shows zero open-market purchases — routine grant/vest/tax-withholding flow only, i.e., a neutral insider tape.

Verdict — a good, disciplined allocator running an average-return model. Management de-levered a large deal in three years, restarted count-shrinking buybacks, retired debt at a discount, pays no wasteful dividend, and runs plans that paid below target when performance lagged — above-average stewardship. But the ultimate scoreboard — ~7.4% group ROIC after 25 years and ~$12.8bn of deals — says capital has been allocated competently rather than brilliantly: value preserved and compounded in absolute cash terms, not multiplied per dollar of capital. The plans reward acquired growth without a capital-return gate, and a ~$9.8M Chairman above the CEO is a legitimate mark-down. Not a top-tier Roper/Danaher value-creation machine.

8. Changes and Headwinds — Last Two Years

1. CEO transition (the governance asterisk). Mehrabian — the architect of the entire roll-up era — stepped back to Executive Chairman; George Bobb III became President & CEO (April 28, 2025), and Edwin Roks departed. This is the single largest governance change in the company’s modern history. Mehrabian was the capital-allocation engine, and the market is paying a re-rated multiple partly on the assumption that the acquisition machine runs unchanged without its founder-operator — unproven. His retained Executive-Chairman role (and top-of-table pay) mitigates but also muddies the new-CEO mandate.
2. The 2024–26 acquisition string. Continued bolt-on cadence (Micropac, Adimec, Qioptiq, TransponderTech, DD-Scientific); FY26 guidance embeds ~0.9% of ~4.9% total growth from M&A — consistent with the historical pattern of many small-to-mid deals. The de-levered balance sheet is dry powder to the bull and pressure to deploy to the bear — a serial acquirer with cash and a 7.4% incremental ROIC is exactly where capital-cycle discipline is most tested.
3. Defense inflection (the clear positive). Book-to-bill >1 for ten straight quarters, ~$4.6bn backlog, and drone/counter-drone/space wins — the strongest fundamental development in years and the proximate cause of the 2026 re-rating.
4. China / export-control / germanium supply chain (a live headwind). Teledyne’s IR/imaging businesses depend on germanium and other China-restricted materials; management is building inventory to buffer supply (a working-capital and FCF-conversion drag). Dual-use controls cut both ways — gating input access and restricting sales into China.
5. Fading FX tailwind. A meaningful slice of 2025’s reported strength was currency (large European/FLIR/Qioptiq footprint); management guides FX benefit toward zero in H2-2026. A reason to discount the headline growth toward the mid-single organic core.
6. Industrial short-cycle recovery (cyclical positive). Test & measurement, machine vision, MEMS and X-ray inflecting off trough — real but cyclical, improving the 2026–27 setup without changing the structural algorithm.

Verdict — net slightly thesis-strengthening, with a governance asterisk. The defense/unmanned/space inflection and the de-levered balance sheet strengthen the near-term thesis; the CEO transition, germanium/export-control exposure, fading FX and the ever-present pressure to keep acquiring at marginal returns are real offsets. On balance the last two years improved the business — but they improved the price faster (see the Valuation discussion), so the changes strengthen the business more than the risk-reward at $652.

9. Risk Analysis

Catastrophic-loss / total-loss question: LOW. Teledyne is a diversified, investment-grade, cash-generative industrial — four uncorrelated segments, no single program or customer large enough to impair the enterprise, ~48% international demand spread, and a ~3.6% FCF yield with high conversion that both services debt and self-funds M&A without depending on capital-market access. The realistic bear case is de-rating and mediocre compounding, not impairment — Risk #1 stacked on Risk #5: paying a full multiple for a ~7.4%-ROIC business, then watching the multiple normalize while organic runs mid-single-digit and a richly-priced deal dilutes returns. That is a drawdown/dead-money outcome, recoverable through time and cash generation — a valuation loss, not a permanent one. The path from “low” to “moderate” (never “total”) is a stacked tail: an overpriced transformational deal that levers the balance sheet, arriving with a defense air-pocket and an industrial downturn. Even then, diversification, cash generation and IG credit make total loss implausible. Catastrophic-loss risk low; drawdown/underperformance risk material, concentrated in valuation and capital allocation.

10. Valuation Discussion (Embedded Expectations)

Where the multiple sits — and the critical correction on the base. At $652.08 (Jul 2 2026) on ~46.2M shares, market cap is ~$30.1bn and, with net debt of ~$1.96–2.0bn, EV ≈ $32bn. That yields, at the current price:

This is the single most important valuation fact: the ~17.4x EV/EBITDA / ~4.5% FCF-yield figures often quoted are the FY2025 year-end levels at a ~$510 stock. The early-2026 breakout re-rated the multiple ~25% higher. The valuation debate must be conducted at today’s ~21x EV/EBITDA / ~3.6% FCF yield. And on own history, EV/Sales at ~5.0–5.1x is approaching the 2021 FLIR-euphoria peak of ~5.2x; own-history percentiles corroborate — P/S in the 92.7th percentile (near richest-ever), P/E 77th, composite 73rd. This is Teledyne priced at the top of its own decade-long range.

Embedded-expectations / reverse-DCF. At EV ~$32bn on ~$1.07bn trailing FCF, the starting FCF yield is ~3.6%. Teledyne is a low-beta name (market beta ~0.78, reported beta ~0.84), so an ~8% cost of capital is defensible. A simple Gordon frame — EV = FCF·(1+g)/(WACC−g) — solves to g ≈ 4.5% perpetual FCF growth. On its face that is consistent with the ~4–5% organic reality: the multiple is not fantastical. The catch is the composition and the returns. To grow FCF ~4.5% forever while organic is only ~4%, Teledyne must keep acquiring — but incremental M&A goes on at a 7.4% ROIC that barely clears the ~8% cost of capital, so it creates little economic value. The clean read: at $652 the market pays ~21x EV/EBITDA for a business whose value-creating organic core grows mid-single-digits and whose growth-supplementing M&A engine earns roughly its cost of capital. The re-rating has front-loaded a defense-multiple premium and an M&A-accretion assumption onto a company that has historically delivered neither in abundance.

Scenario analysis (2028E) — explicit assumptions, no price target.

The base case roughly earns the equity cost of capital from here — mid-to-high-single-digit EPS growth at a multiple that holds, an adequate, not compelling, forward return. The bull case requires the defense supercycle to persist and a return to value-accretive large-scale M&A without the founder-CEO. The bear case is not a blow-up but a de-rating: a low-7% ROIC serial acquirer at ~21x EV/EBITDA and the 92nd P/S percentile has clear compression risk if organic slips back toward 3% and the momentum bid fades.

Peer comparison (approximate, TTM; ROIC.ai price snapshots vary).

On EV/Sales (~5.0x) Teledyne screens cheaper than AME/DHR/MTD/ROP — but only because its margins and returns are lower. On the margin-neutral EV/EBITDA (~21x), TDY sits mid-cohort — fully priced, not cheap — and its GAAP P/E (~32–34x) is inflated by heavy acquisition amortization. The only names clearly richer (CW, MTD, AME) are structurally higher-return businesses. Teledyne is not the cheap way to own the instrument-compounder theme; it is an average-return version of it trading at a full-cohort multiple, carrying a defense-inflection option that is real but already substantially in the price.

Valuation verdict. At $652 the market is paying a defense-inflection + M&A-optionality premium on a business that organically grows mid-single-digits and earns a ~7.4% ROIC. The embedded ~4.5% perpetual FCF growth is achievable — but only if Teledyne keeps deploying capital at returns that barely beat its cost of capital, and only if the 2026 defense wave proves durable. The multiple has moved from “reasonable for the quality” (year-end 2025) to “priced for the good case” (mid-2026). (No price target; scenario framing only.)

11. Variant Perception

Consensus view. The Street is constructively bullish (~18 analysts, ~79% buy-rated, average target ~$750; 2026 non-GAAP EPS consensus ~$24, 2027 ~$26). The narrative: a de-risked, low-beta compounder that has finally inflected — real, multi-year defense/unmanned/space demand; a de-levered balance sheet for M&A; record margins; an orderly founder-to-successor transition. In short, “quality industrial-tech at a defensible premium with a defense kicker.”

Strongest bull case. A genuine defense supercycle (drones, counter-drone, EW, space/Golden Dome, maritime autonomy) meets a re-armed West and a proven acquisition machine on ~1.5x-levered dry powder and >$1bn/yr FCF. Book-to-bill above 1 for ten straight quarters and a $4.6bn backlog say the order momentum is durable, not a spike; record operating margins show leverage on the way up; industrial short-cycle recovery adds a second engine. If organic runs 6–8% and TDY layers on accretive M&A, the re-rating to ~21x EV/EBITDA is justified and extendable — a defense-tech name still priced like a diversified industrial.

Strongest bear case. A low-7% ROIC serial acquirer whose multi-year revenue was largely bought (FLIR), whose crown-jewel acquisition was a mediocre asset that only worked when an exogenous war-demand shock arrived, and whose organic algorithm is ~4%. It now trades at the 92.7th percentile of its own P/S history, ~21x EV/EBITDA and ~32x GAAP earnings — a full-cohort multiple on a below-cohort-return business. The 2026 move is a momentum re-rating (a low-vol defensive that flipped into a defense-beta trade), not an earnings breakout — non-GAAP EPS grew ~8–17% while the multiple expanded ~25%. The founder-CEO who was the capital-allocation edge is stepping back; germanium/export-control exposure and fading FX are live drags. If the defense wave normalizes and industrial recovery stalls, estimates and the multiple compress together.

The 3–5 assumptions that matter most (and what falsifies each).

1. Defense/unmanned demand is a multi-year supercycle, not a 2024–26 spike. Bear-falsify: book-to-bill below 1.0 for 2+ quarters, or unmanned/FLIR-Defense growth decelerating to low-single-digits. Bull-falsify: orders keep compounding and Golden Dome/SDA awards convert to revenue.
2. Organic growth is durably ~5%+ (not ~3–4%). Bear: a return to a 2024-style flat year once FX and defense one-timers wash out. Bull: two-plus consecutive years of ~6%+ organic across multiple segments.
3. M&A creates value (ROIC rises toward low-double-digits). Bear: ROIC stays stuck at ~7–8% as fresh deals dilute returns, or a large deal lands at a full multiple. Bull: incremental deals lift consolidated ROIC and margins.
4. The Mehrabian→successor transition preserves capital-allocation discipline. Bear: an out-of-pattern, richly-priced acquisition or strategy drift. Bull: continued disciplined bolt-ons at sensible multiples.
5. The multiple holds at ~21x EV/EBITDA / 92nd-percentile P/S. Bear: factor rotation out of defense/momentum de-rates the tape regardless of fundamentals. Bull: the defense-tech re-rating proves sticky (CW-style permanence).

Factor-positioning read (FactorsToday). TDY is a low-market-beta (~0.78), Industrials-sector name that flipped into a momentum/defense-beta trade in 2026: m6 return ~+63% annualized (Sharpe ~2.0), y1 ~+28% (Sharpe ~1.01) — strong recent risk-adjusted performance — against a long-run profile (y5 ~+8.8% annualized, lifetime max drawdown −66%) that shows a stock that can round-trip hard. Factor-similar peers are mostly industrial ETFs plus Wabtec — the market currently classifies TDY as a defensive-industrial re-tagged as a defense-momentum name. This corroborates the bear’s “momentum re-rating” framing: the 2026 gain is a factor/sentiment shift (defensive → defense-beta), exactly the kind of crowding that unwinds on a growth wobble or factor rotation. Evidence of where consensus may be offsides, not a price call.

12. Fact vs. Interpretation Table

13. Open Questions

1. What is the true underlying organic growth rate through a full cycle once FX, defense one-timers and industrial mean-reversion are stripped — is it durably 5%+, or the ~3–4% the FY23–24 record implies?
2. Can the Mehrabian→Bobb transition preserve the acquisition discipline? The next one or two capital-allocation decisions (multiple paid, size, fit) are the real test — will the new CEO chase scale, or hold the line?
3. Will incremental M&A finally lift group ROIC, or will each fresh deal keep pinning returns near WACC? Is there any deal size/price at which management would break pattern?
4. How durable is the defense/unmanned demand beyond the current conflicts — is Black Hornet/Rogue 1/counter-UAS a structural program of record, or a rearmament-cycle spike?
5. What is the real germanium/export-control exposure, and how much working-capital drag will the inventory-buffering strategy impose on FCF conversion?
6. What non-GAAP add-backs beyond amortization is management including, and is the ~$24 FY26 non-GAAP EPS a clean cash proxy? (The earnings-release reconciliation exhibit was not in the mirrored corpus.)
7. Is there SOTP value — would separating the high-margin Instrumentation and defensible IR/space assets from the lower-return Digital-Imaging-commercial and Engineered-Systems lines surface value the conglomerate structure obscures?

14. What Must Be True

Bull case — what must be true, and its falsification test. For the ~21x EV/EBITDA multiple to be justified and extendable, Teledyne must (a) sustain ~6%+ organic growth as the defense/unmanned/space demand proves structural (not a 2024–26 spike), (b) convert its ~1.5x-levered balance sheet and >$1bn/yr FCF into value-accretive M&A that finally lifts group ROIC toward low-double-digits — under a new CEO — and © hold or expand margins on defense/T&M mix. Falsification test: book-to-bill falls below 1.0 for two-plus consecutive quarters, or group ROIC fails to rise above ~8% over the next two-to-three years despite continued deal-making, or a large acquisition lands at a full multiple that dilutes returns. Any one of these breaks the “re-rating is justified” thesis.

Bear case — what must be true, and its falsification test. For the bear (de-rating, dead money), Teledyne must (a) revert to ~3–4% organic once FX and defense one-timers wash out, (b) keep earning only ~WACC on incremental capital, and © suffer multiple compression as the momentum/defense-beta bid unwinds from the 92nd P/S percentile. Falsification test: two-plus consecutive years of ~6%+ organic growth across multiple segments and a visible rise in group ROIC toward low-double-digits and a defense order book that keeps compounding (backlog and book-to-bill rising). If all three hold, the “average compounder at the wrong price” thesis is wrong and the premium is earned.

15. Source Appendix

See Appendix B (Source Appendix) below for the full, categorized source list with URLs and access dates. Primary sources: Teledyne FY2025 Form 10-K (filed 2026-02-20), FY2021–FY2024 10-Ks, Q1-2026 10-Q (filed 2026-04-24), 2026 DEF 14A (filed 2026-03-12), Form 4 corpus, Q1-2026 earnings-call transcript (2026-04-22) and Q4-2025 earnings release (2026-01-21). Quantitative cross-checks: ROIC.ai (statements, ratios, EV, multiples), FactorsToday factor model. Peer context from public filings and market data on AME, ROP, DHR, A, MTD, CW, DOV, LHX; industry context via public trade sources.

APPENDIX A — Standard Diligence Questionnaire

Teledyne Technologies Incorporated (NYSE: TDY) — supplemental to the research memo (report date 2026-07-04). Answers grounded in the analysis; Fact/Interpretation/Assumption labeled where it matters.

General

What thoughtful questions have other investors asked about this company? The recurring institutional debate is captured almost verbatim in the Q1-2026 call: (1) “Are you rubbing up against more competitors on M&A, and are sellers demanding outrageous prices?” (crowded roll-up space) — Mehrabian conceded “yes, it’s getting crowded” and that buyers “are willing to pay some outrageous prices”; (2) does strong defense book-to-bill translate to near-term revenue, given short- vs long-cycle mix?; (3) how much of the growth is organic vs FX vs acquired?; and (4) is the unmanned/counter-drone business (~$500M) being under-guided? The skeptical buy-side question the memo foregrounds — why has group ROIC been stuck at ~7.4% for four years? — is the one the sell-side rarely presses.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Mid-to-high. Defense/space/unmanned is inflecting up (arguably early-to-mid cycle on a rearmament wave); short-cycle industrial (machine vision, T&M, X-ray) is recovering off a 2023–24 trough; margins are at record highs (24.3% EBITDA). So the blend is closer to a cyclical high on margin, mid-cycle on demand. Interpretation.

Driven by external environment or internal actions? Both, but the 2025–26 acceleration is substantially external — European/Ukraine/Middle East rearmament, Golden Dome/SDA budgets, and FX — layered on internal margin/integration work. Strip the exogenous defense shock and the organic algorithm is ~4%.

How stable are revenues? Moderately. ~40% is over-time (defense/engineered project) with a $4.6bn backlog (0.75x sales); ~60% is short-cycle product sales tied to industrial/semiconductor capex. No recurring/subscription annuity — do not model software-like stability.

Outlook for products/services; how big is the market — growing/shrinking, domestic/international? Growing in defense EO/IR (~$15bn by 2035), space sensing, counter-UAS, and machine vision (~8% CAGR); flat-to-shrinking in Engineered Systems (NASA budget pressure). ~48% international and rising.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? The operating niches are stable oligopolies (thermal/IR, oscilloscopes, subsea); the M&A market to buy such businesses is getting more competitive and expensive (AMETEK, Roper, Danaher, Halma, sponsors).

How profitable is the business (ROIC, ROE)? Reported ROIC ~7.4%, ROE 13.3%, ROA 6.1% — mediocre for a “quality compounder.” But tangible ROIC ~45% (ex-goodwill): the operating businesses are excellent; the enterprise, at prices paid, earns ~WACC. This gap is the whole thesis.

How profitable is the industry — how many competitors, what barriers to entry? Barriers are real inside niches (detector fabs, qualification cycles, ITAR, flight heritage, designed-in components) — hence 25–28% segment margins in Instrumentation/A&D. Few competitors per niche; entry is capital- and know-how-gated.

Can the business be easily understood? Reasonably at the model level (buy-and-optimize niche instruments), but the 4-segment, dozen-end-market sprawl and heavy purchase-accounting make the financials opaque (GAAP vs non-GAAP, volatile tax, negative tangible book).

Undermined by foreign low-cost labor? Limited — high-reliability, low-volume, regulated/ITAR hardware. But subsidized Asian competition (machine-vision sensors) and local-content rules (EU/China/India) erode edges of the addressable market.

Do brands matter? Yes, within technical buying: FLIR, LeCroy, DALSA, e2v, Qioptiq carry genuine engineering brand equity and installed-base pull.

Nature of competition / customers’ switching costs? Competition is on performance, reliability and qualification, not price. Switching costs are real where components are designed-in to platforms (A&D, subsea, protocol analyzers) and weak where Teledyne is a merchant sensor supplier (machine vision).

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The operating businesses’ economic value (tangible ROIC ~45%) is understated relative to their ~$2bn tangible capital — but that value is already capitalized as goodwill, so it is on the balance sheet as intangibles, not hidden.

Off-balance-sheet liabilities? Nothing material flagged; standard operating leases, pension, and legacy FLIR trade-compliance/tax matters (open, not quantified as material). Open question.

How conservative is the accounting? Broadly conservative — no capitalized-software games, amortization fully disclosed and scheduled. But watch the volatile tax line (discrete-item-driven) and the recurring “adjusted” add-back of permanent amortization.

How CapEx-hungry? Very light — CapEx <2% of sales (~$117M FY25, rising to ~$150M FY26). A low-capital-intensity cash compounder.

Capital Allocation & Management

How much FCF, how is it used, what is the philosophy? ~$1.07bn FCF FY25 (1.2x conversion). Priority order: bolt-on/mid-size M&A first, then buybacks, then debt reduction; no dividend. Philosophy: disciplined-on-leverage serial acquisition + programmatic buyback.

Significant acquisitions recently? Yes — Qioptiq (~$703M, 2025), plus Micropac, Adimec, TransponderTech, DD-Scientific; ~$821M cash deployed in FY25. FLIR (~$8bn, 2021) is the defining historical deal.

Buying back shares? Yes — $403M FY25 / $354M FY24, enough to shrink the count; new $2.0bn authorization (July 2025). Bought near record highs (programmatic, not value-timed).

Issuing large amounts of stock to insiders? No — SBC is ~0.65% of revenue; the share count is falling.

Compensation policy of directors/management? AIP = 40% adj pre-tax income / 25% adj revenue / 15% managed working capital / 20% individual; LTIP = 3-yr revenue, EPS, working capital, relative TSR (paid below target 2023–25). No explicit ROIC/return-on-capital gate — a governance gap. Say-on-Pay 95.6%.

Motivations of management? Professional managers, not owner-operators (insiders own 1.3%). Governance flag: Exec Chairman Mehrabian is the highest-paid officer ($9.79M > CEO Bobb $4.26M) — a succession/key-person overhang. No open-market insider buying.

Valuation & Market Data

ADR / MLP / K-1 issuer? No — U.S. C-corp common stock, NYSE-listed. Standard 1099.

Dividend policy? None; none contemplated (“do not anticipate paying any cash dividends in the foreseeable future,” 10-K).

How profitable is the business? 42.8% gross, 18.8% operating, 24.3% EBITDA, 14.6% net margins; ~$894.8M net income FY25.

Is net income diverging from cash from operations? Favorably — OCF ($1,191M) and FCF ($1,074M) exceed net income ($894.8M) at ~1.2–1.3x, helped by ~$217M non-cash amortization. No adverse divergence.

Risks & Downside

What factors would cause the stock to decline? Multiple compression from the 92nd-percentile P/S (momentum/defense-beta unwind); organic reverting to ~3%; an out-of-pattern richly-priced deal; book-to-bill rolling under 1.0; germanium/export-control disruption; a CEO-transition misstep.

Risk of catastrophic loss? Low — diversified, IG-rated, cash-generative, no single program/customer large enough to impair the enterprise.

Chance of a total loss? Implausible — investment-grade balance sheet, self-funding cash engine, four uncorrelated segments. The realistic downside is drawdown/dead-money (valuation loss), not permanent impairment.

Recent News & Events

Has the business environment changed recently? Yes — a genuine 2025–26 defense/unmanned/counter-drone/space demand inflection (book-to-bill >1 for ten quarters), plus CEO transition (Bobb→CEO Apr-2025, Mehrabian→Exec Chairman) and a raised FY26 guide.

Significant acquisitions? DD-Scientific (Jan-2026), TransponderTech (Nov-2025), Qioptiq/Adimec/Micropac (2024–25).

Change in accounting policies? None material flagged; a July-2025 U.S. tax act modestly cut cash taxes.

Recent changes — new markets, facilities, management? Capacity investments (germanium machining, MEMS expansion in Edmonton), higher CapEx/R&D, and the leadership transition are the notable moves.

APPENDIX B — Source Appendix

Teledyne Technologies Incorporated (NYSE: TDY) — research memo dated 2026-07-04. Primary sources first. Fact/Interpretation separation is maintained in the memo body; this appendix lists the evidence base.

1. Primary — SEC filings (CIK 0001094285)

• Form 10-K, FY2025 (filed 2026-02-20; period ended 2025-12-28) — income statement, balance sheet, cash flow; segment revenue/operating income; goodwill & intangibles; backlog/RPO; debt maturities; buyback authorization; customer/geographic mix; tax note. https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001094285&type=10-K
• Form 10-K, FY2021–FY2024 (filed 2022-02-25, 2023-02-24, 2024-02-23, 2025-02-21) — multi-year margin/ROIC trend; FLIR-integration history; FY24 $52.5M trademark impairment.
• Form 10-Q, Q1-2026 (filed 2026-04-24; period ended 2026-03-29) — Q1 revenue +7.6%/organic +6.9%, book-to-bill 1.16, tax rate 18.6% / $8.0M discrete benefit.
• DEF 14A / Proxy, 2026 (filed 2026-03-12) — executive compensation (Mehrabian $9,787,488; Bobb $4,255,049), AIP/LTIP metrics, Say-on-Pay 95.6%, insider ownership (directors+officers 1.3%), 13G holders (Vanguard 12.9%, BlackRock 8.9%, T. Rowe 6.8%), classified board.
• Form 4 corpus (226 filings, trailing 60 months) — insider-transaction sweep: codes M/A/F only, no open-market (P) purchases.
• Form 8-K — Q4-2025 earnings release (2026-01-21); leadership-transition and M&A disclosures.

2. Primary — Earnings materials

• Q1-2026 earnings-call transcript (2026-04-22) — FY26 guidance ($6.415bn rev; GAAP EPS $20.08–$20.44; non-GAAP $23.85–$24.15); segment book-to-bill; unmanned/defense/M&A commentary; FLIR-Defense +9%; M&A “outrageous prices” exchange. Source: ROIC.ai transcript tool; public transcript (Motley Fool). https://www.fool.com/earnings/call-transcripts/2026/04/22/teledyne-tdy-q1-2026-earnings-call-transcript/
• Q4-2025 earnings release (2026-01-21) — record quarter; +9.8% single-day stock move (breakout catalyst). https://www.businesswire.com/news/home/20260121818387/en/

3. Quantitative cross-checks (third-party aggregated; reconciled to filings)

• ROIC.ai MCP — income statement, balance sheet, cash flow, profitability/credit/per-share ratios, enterprise value, valuation multiples (FY2020–2025 pulls). Used for ROIC ~7.4%, EBITDA $1,486M, EV, tangible book −$5.93/sh, peer ratios.
• Own-history valuation percentiles (P/E 77th, P/B 50th, P/S 92.7th, composite 73rd; ttm_eps $19.76, price $652.08 as of 2026-07-02).
• Five-year price history — OHLCV, EMAs, beta 0.84; the five-year event-map price points (ATH $688.60 on 2026-03-02; 52-week range $484.50–$688.60).
• Company news feed — recent-events scan (Teledyne FLIR Defense product/contract announcements, Eurosatory 2026, e2v space-grade ADC, MEMS Edmonton expansion).
• FactorsToday factor model — stock loadings (market beta ~0.78, Industrials sector), leaderboard (y1 +28%/Sharpe 1.01; m6 +63% annualized/Sharpe 2.0; y5 +8.8%; lifetime max drawdown −66%), related-stocks (industrial ETFs + WAB).

4. Peer / cohort context (public filings & market data)

• Peers used for the instrument-compounder comps table and quality/valuation positioning: AME (AMETEK — closest mirror), ROP (Roper), DHR (Danaher), A (Agilent), MTD (Mettler-Toledo), CW (Curtiss-Wright), DOV (Dover), LHX (L3Harris) — from their public filings and market data.
• Public estimate/target context (consensus ~79% buy, avg target ~$750, 2026 EPS ~$24 / 2027 ~$26): WallStreetZen, stockanalysis.com.

5. Industry / market data

• Machine vision, thermal/IR & defense EO/IR, test & measurement, and subsea market sizing/share from public trade sources. Regulatory context (ITAR/EAR, China export controls, germanium, EU local-content) from filings and public reporting.

6. Analytical frameworks

• Competition Demystified (Greenwald & Kahn) — moat-type taxonomy, share-stability and ROIC-vs-WACC tests (applied in Section 4).
• Capital Returns (Marathon) — supply-side capital-cycle lens on the crowded/expensive roll-up market (applied in Section 3).

All URLs accessed 2026-07-03/04. Third-party aggregated market data is used as a cross-check; SEC filings are primary and authoritative where they disagree.